eMagin (NYSE:EMA – Get Free Report) had its price objective decreased by research analysts at Barclays from $53.00 to $52.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s target price would indicate a potential downside of 1.87% from the company’s previous close.
Other equities analysts have also issued reports about the company. Bank of America lowered eMagin from a “buy” rating to a “neutral” rating in a research note on Monday, January 12th. Wall Street Zen raised eMagin from a “strong sell” rating to a “sell” rating in a research report on Saturday, April 18th. One analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $56.33.
Get Our Latest Stock Report on EMA
eMagin Price Performance
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the company. State of Tennessee Department of Treasury acquired a new position in eMagin in the second quarter valued at approximately $7,749,000. Russell Investments Group Ltd. boosted its stake in eMagin by 22.5% during the fourth quarter. Russell Investments Group Ltd. now owns 131,852 shares of the company’s stock valued at $6,506,000 after buying an additional 24,241 shares in the last quarter. Parallel Advisors LLC raised its position in eMagin by 130.9% in the first quarter. Parallel Advisors LLC now owns 508 shares of the company’s stock worth $26,000 after acquiring an additional 288 shares in the last quarter. DGS Capital Management LLC acquired a new stake in eMagin in the 1st quarter valued at about $349,000. Finally, Venturi Wealth Management LLC lifted its stake in eMagin by 12.1% during the first quarter. Venturi Wealth Management LLC now owns 8,111 shares of the company’s stock valued at $421,000 after purchasing an additional 877 shares during the last quarter.
eMagin Company Profile
eMagin Corporation engages in the design, develop, manufacture, and market of organic light-emitting diode (OLED) miniature displays on-silicon micro displays, virtual imaging products that utilize OLED micro displays, and related products in the United States and internationally. It offers super video graphics array (SVGA) + OLED micro displays; digital SVGA OLED-XL; super extended graphics array OLED-XL/XLS; video graphics array OLED-XL; and widescreen ultra-extended graphics array OLED-XL. The company also provides design reference kits, which include a micro display and associated electronics to help original equipment manufacturers (OEMs) to evaluate micro display products; near-eye virtual imaging modules that incorporate its OLED-on-silicon micro displays with its lenses and electronic interfaces for integration into OEM products; prism optics, a molded plastic prism lens that permits its AMOLED micro displays to provide realistic images that can be viewed for extended periods with reduced eye-fatigue; and driver boards.
Featured Stories
- Five stocks we like better than eMagin
- Catching Falling Knives: Is Time to Buy These Beaten-Down Stocks?
- The Stars Are Aligning For Apple: Get Ready for $300
- 3 Small-Cap Stocks to Buy as the Russell 2000 Extends Its Rally
- Tapestry Stock Drops After Strong Quarter and Raised Outlook
Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.
